Hematology Oncology Consultants

Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non–Small-Cell Lung Cancer Previously Treated With Immunotherapy—Lung-MAP S1800A

Karen L. Reckamp, Mary W. Redman, Konstantin H. Dragnev et al. · Journal of Clinical Oncology · 2022 · 228 citations · Full text

Positron Emission Tomography–Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001

Daniel O. Persky, Hongli Li, Deborah M. Stephens et al. · Journal of Clinical Oncology · 2020 · 119 citations · Full text

SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer

Zeina Nahleh, William E. Barlow, Daniel F. Hayes et al. · Breast Cancer Research and Treatment · 2016 · 84 citations · Full text

Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group

A. Jatoi, Brian R. Murphy, Nathan R. Foster et al. · Annals of Oncology · 2005 · 65 citations · Full text

Surgical Oncology, Esophageal Cancer, Gastric Cardia +9

Effects of the Removal of the Tracheotomy Tube on Swallowing During the Fiberoptic Endoscopic Exam of the Swallow (FEES)

Joseph Donzelli, Susan Brady, Michele Wesling et al. · Dysphagia · 2005 · 65 citations

Gross Anatomy, Tracheotomy Tube, Interventional Pulmonology +12